Your browser doesn't support javascript.
loading
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Minarik, Jiri; Pavlicek, Petr; Pour, Ludek; Pika, Tomas; Maisnar, Vladimir; Spicka, Ivan; Jarkovsky, Jiri; Krejci, Marta; Bacovsky, Jaroslav; Radocha, Jakub; Straub, Jan; Kessler, Petr; Wrobel, Marek; Walterova, Lenka; Sykora, Michal; Obernauerova, Jarmila; Brozova, Lucie; Gregora, Evzen; Adamova, Dagmar; Gumulec, Jaromir; Adam, Zdenek; Scudla, Vlastimil; Hajek, Roman.
Afiliação
  • Minarik J; Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic.
  • Pavlicek P; Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Praha, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Pika T; Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic.
  • Maisnar V; Department of Clinical Hematology, University Hospital, Hradec Kralove, Czech Republic.
  • Spicka I; Department of Internal Medicine, University Hospital, Praha, Czech Republic.
  • Jarkovsky J; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Krejci M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Bacovsky J; Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic.
  • Radocha J; Department of Clinical Hematology, University Hospital, Hradec Kralove, Czech Republic.
  • Straub J; Department of Internal Medicine, University Hospital, Praha, Czech Republic.
  • Kessler P; Department of Hematology and Transfusion, General Hospital, Pelhrimov, Czech Republic.
  • Wrobel M; Department of Oncology, Hospital Novy Jicin, Novy Jicin, Czech Republic.
  • Walterova L; Department of Clinical Hematology, General Hospital Liberec, Liberec, Czech Republic.
  • Sykora M; Department of Clinical Hematology, General Hospital, Ceske Budejovice, Czech Republic.
  • Obernauerova J; Department of Hematology and Transfusion, Claudian Hospital, Mlada Boleslav, Czech Republic.
  • Brozova L; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Gregora E; Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Praha, Czech Republic.
  • Adamova D; Department of Hematology and Transfusiology, Silesian Hospital, Opava, Czech Republic.
  • Gumulec J; Department of Haematooncology, University Hospital Ostrava and the Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Adam Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Scudla V; Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic.
  • Hajek R; Department of Haematooncology, University Hospital Ostrava and the Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
PLoS One ; 10(4): e0123866, 2015.
Article em En | MEDLINE | ID: mdl-25875484
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Periférico / Bortezomib / Mieloma Múltiplo Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: República Tcheca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Periférico / Bortezomib / Mieloma Múltiplo Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: República Tcheca